Chad Messer
Stock Analyst
(n/a)
# 4,425
Out of 4,433 analysts
20
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics | Maintains: Strong Buy | n/a | $2.59 | - | 2 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | n/a | $17.66 | - | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | n/a | $59.92 | - | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | n/a | $21.23 | - | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | n/a | $28.72 | - | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | n/a | $5.20 | - | 2 | May 14, 2021 | |
| MREO Mereo BioPharma Group | Initiates: Buy | n/a | $3.27 | - | 1 | Apr 5, 2021 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | n/a | $37.62 | - | 2 | Mar 23, 2021 | |
| IMAB I-Mab | Initiates: Buy | n/a | $1.77 | - | 1 | Mar 15, 2021 | |
| GTHX G1 Therapeutics | Maintains: Buy | n/a | $4.68 | - | 2 | Feb 25, 2021 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | n/a | $132.74 | - | 1 | Jan 8, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $15.40 | - | 1 | Aug 18, 2020 | |
| AKBA Akebia Therapeutics | Maintains: Buy | n/a | $1.14 | - | 1 | May 5, 2020 |
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: n/a
Current: $2.59
Upside: -
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: n/a
Current: $17.66
Upside: -
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: n/a
Current: $59.92
Upside: -
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: n/a
Current: $21.23
Upside: -
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: n/a
Current: $28.72
Upside: -
CorMedix
May 14, 2021
Maintains: Buy
Price Target: n/a
Current: $5.20
Upside: -
Mereo BioPharma Group
Apr 5, 2021
Initiates: Buy
Price Target: n/a
Current: $3.27
Upside: -
Ionis Pharmaceuticals
Mar 23, 2021
Maintains: Buy
Price Target: n/a
Current: $37.62
Upside: -
I-Mab
Mar 15, 2021
Initiates: Buy
Price Target: n/a
Current: $1.77
Upside: -
G1 Therapeutics
Feb 25, 2021
Maintains: Buy
Price Target: n/a
Current: $4.68
Upside: -
Sarepta Therapeutics
Jan 8, 2021
Maintains: Buy
Price Target: n/a
Current: $132.74
Upside: -
Nurix Therapeutics
Aug 18, 2020
Initiates: Buy
Price Target: n/a
Current: $15.40
Upside: -
Akebia Therapeutics
May 5, 2020
Maintains: Buy
Price Target: n/a
Current: $1.14
Upside: -